Free stock market and financial news API
Instant access to global stock market and finance news also including funds, crypto and more along with comprehensive sentiment analysis.
{
"meta": {
"found": 12320,
"returned": 5,
"limit": 5,
"page": 1
},
"data": [
{
"uuid": "c491176b-6f6f-47a9-afdf-dd5abb07d9e9",
"title": "Roblox (RBLX) Shares Surge Amid Tech Sector Optimism",
"description": "Roblox (RBLX) shares jump 10% as tech sector confidence strengthens. Analysts project a potential 9% upside for Roblox stock, with strong forecasts from",
"keywords": "GuruFocus, Article, News, GuruFocus News, RBLX",
"snippet": "Roblox (RBLX, Financial) shares jump 10% as tech sector confidence strengthens.\n\nAnalysts project a potential 9% upside for Roblox stock, with strong forecasts ...",
"url": "https://www.gurufocus.com/news/2806626/roblox-rblx-shares-surge-amid-tech-sector-optimism",
"image_url": "https://static.gurufocus.com/logos/0C0000BZQA.png?20",
"language": "en",
"published_at": "2025-04-26T20:55:29.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "RBLX",
"name": "Roblox Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 74.64673,
"sentiment_score": 0.434543,
"highlights": [
{
"highlight": "<em>Roblox</em> (<em>RBLX</em>, Financia[+289 characters]",
"sentiment": 0.9217,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>RBLX</em>), a prominent player in t[+218 characters]",
"sentiment": 0.8519,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts' Insights\n\n<em>Robl[+266 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into these estimates, [+309 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "According to GuruFocus estimates, the GF[+183 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "For further details, visit the <em>Roblo[+41 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Roblox</em> (<em>RBLX</em>) Shares Surge Amid Tech Sector Optimism",
"sentiment": 0.6908,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "b10a097b-a525-4ea1-8b6f-740d170cbd42",
"title": "Medtronic (MDT) Seeks FDA Approval for Hugo Robotic Surgery System",
"description": "Key Insights:\n Medtronic seeks FDA approval for its cutting-edge Hugo robotic-assisted surgery system. Analysts project a potential 13.96% upside for Medt",
"keywords": "GuruFocus, Article, News, GuruFocus News, MDT",
"snippet": "Key Insights:\n\nMedtronic seeks FDA approval for its cutting-edge Hugo robotic-assisted surgery system.\n\nAnalysts project a potential 13.96% upside for Medtronic...",
"url": "https://www.gurufocus.com/news/2806625/medtronic-mdt-seeks-fda-approval-for-hugo-robotic-surgery-system",
"image_url": "https://static.gurufocus.com/logos/0C000008BI.png?20",
"language": "en",
"published_at": "2025-04-26T20:55:27.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MDT",
"name": "Medtronic plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 60.74964,
"sentiment_score": 0.461586,
"highlights": [
{
"highlight": "Key Insights:\n\n<em>Medtronic</em> seeks [+275 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Medtronic's Bold Move into Robotic Surge[+217 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "These promising outcomes meet primary go[+307 characters]",
"sentiment": 0.872,
"highlighted_in": "main_text"
},
{
"highlight": "For more in-depth forecasts, refer to th[+201 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Valuation Insights from GuruFocus\n\nAccor[+275 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "For additional analysis and data, visit [+55 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medtronic</em> (MDT) Seeks FDA Approval for Hugo Robotic Surgery System",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "41f34be8-5663-49b1-a470-92ac976f8e04",
"title": "Medtronic PLC (MDT) Achieves Key Milestone with Hugo RAS System in U.S. Clinical Trial | MDT stock news",
"description": "Summary On April 26, 2025, Medtronic PLC (MDT), a leader in healthcare technology, announced that its Expand URO Investigational Device Exemption (IDE) clinical",
"keywords": "GuruFocus, Article, News, GuruFocus News, MDT",
"snippet": "Summary\n\nOn April 26, 2025, Medtronic PLC (MDT, Financial), a leader in healthcare technology, announced that its Expand URO Investigational Device Exemption (I...",
"url": "https://www.gurufocus.com/news/2806616/medtronic-plc-mdt-achieves-key-milestone-with-hugo-ras-system-in-us-clinical-trial-mdt-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-04-26T20:01:26.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MDT",
"name": "Medtronic plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 73.432945,
"sentiment_score": 0.25442,
"highlights": [
{
"highlight": "Summary\n\nOn April 26, 2025, <em>Medtroni[+217 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medtronic</em> has submitted the Hug[+304 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nThe[+160 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "The FDA submission is a crucial step for[+325 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medtronic</em> <em>PLC</em> (MDT) Achieves Key Milestone with Hugo RAS System in U.S. Clinical Trial | MDT stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "2M6.DE",
"name": "Medtronic plc",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 73.41982,
"sentiment_score": 0.25442,
"highlights": [
{
"highlight": "Summary\n\nOn April 26, 2025, <em>Medtroni[+217 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medtronic</em> has submitted the Hug[+304 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nThe[+160 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "The FDA submission is a crucial step for[+325 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medtronic</em> <em>PLC</em> (MDT) Achieves Key Milestone with Hugo RAS System in U.S. Clinical Trial | MDT stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MDTN.MX",
"name": "Medtronic plc",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 73.41373,
"sentiment_score": 0.25442,
"highlights": [
{
"highlight": "Summary\n\nOn April 26, 2025, <em>Medtroni[+217 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medtronic</em> has submitted the Hug[+304 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nThe[+160 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "The FDA submission is a crucial step for[+325 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medtronic</em> <em>PLC</em> (MDT) Achieves Key Milestone with Hugo RAS System in U.S. Clinical Trial | MDT stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0Y6X.L",
"name": "Medtronic plc",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 73.398575,
"sentiment_score": 0.25442,
"highlights": [
{
"highlight": "Summary\n\nOn April 26, 2025, <em>Medtroni[+217 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medtronic</em> has submitted the Hug[+304 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nThe[+160 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "The FDA submission is a crucial step for[+325 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medtronic</em> <em>PLC</em> (MDT) Achieves Key Milestone with Hugo RAS System in U.S. Clinical Trial | MDT stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "3430fa3c-8636-4aa9-ac55-83736f1598ba",
"title": "Medtronic seeks FDA nod for Hugo robotic surgery system (MDT)",
"description": "Medtronic (MDT) seeks FDA nod for its Hugo robotic-assisted surgery system, targeting urology, and announce data from a clinical trial for the product. Read more here.",
"keywords": "",
"snippet": "Medtronic (NYSE:MDT) confirmed on Saturday the submission of regulatory filings with the FDA to obtain marketing approval for its Hugo robotic-assisted surgery ...",
"url": "https://seekingalpha.com/news/4436057-medtronic-seeks-fda-nod-hugo-robotic-surgery-system",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1214270370/image_1214270370.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2025-04-26T19:17:09.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MDT",
"name": "Medtronic plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 52.396423,
"sentiment_score": 0.23835,
"highlights": [
{
"highlight": "<em>Medtronic</em> (<em>NYSE:MDT</em>) c[+245 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medtronic</em> seeks FDA nod for Hugo robotic surgery system (MDT)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "e30a225b-7f83-4bee-8d25-827b3f38a4f1",
"title": "Iridium Communications (IRDM) Sees Shares Drop Despite Strong Earnings",
"description": "Key Takeaways:\n Iridium Communications saw revenues grow by 5% and a significant leap in net income, yet the stock fell by 6.85%. Analysts forecast a subs",
"keywords": "GuruFocus, Article, News, GuruFocus News, IRDM",
"snippet": "Key Takeaways:\n\nIridium Communications saw revenues grow by 5% and a significant leap in net income, yet the stock fell by 6.85%.\n\nAnalysts forecast a substanti...",
"url": "https://www.gurufocus.com/news/2806624/iridium-communications-irdm-sees-shares-drop-despite-strong-earnings",
"image_url": "https://static.gurufocus.com/logos/0C00001843.png?20",
"language": "en",
"published_at": "2025-04-26T20:55:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "IRDM",
"name": "Iridium Communications Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 101.25257,
"sentiment_score": 0.2801,
"highlights": [
{
"highlight": "Key Takeaways:\n\n<em>Iridium</em> <em>Com[+210 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Iridium</em> <em>Communications</em>[+266 characters]",
"sentiment": 0.6945,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts' Forecast\n\nAccordin[+311 characters]",
"sentiment": -0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "For more in-depth analysis, visit the <e[+312 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "GF Value Assessment\n\nGuruFocus estimates[+317 characters]",
"sentiment": 0.9022,
"highlighted_in": "main_text"
},
{
"highlight": "For further details, explore the <em>Iri[+67 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Iridium</em> <em>Communications</em> (IRDM) Sees Shares Drop Despite Strong Earnings",
"sentiment": -0.1466,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "fcc40055-f7b0-4de5-ae89-60a2a4f653b5",
"title": "BEAM to Discuss Advances in AATD Therapy at Upcoming Conference Call | BEAM Stock News",
"description": "A significant discussion surrounding advancements in the Alpha-1 Antitrypsin Deficiency (AATD) therapeutic field is set for April 28 at 10 a.m. on an analyst an",
"keywords": "GuruFocus, Article, News, GuruFocus News, BEAM",
"snippet": "A significant discussion surrounding advancements in the Alpha-1 Antitrypsin Deficiency (AATD) therapeutic field is set for April 28 at 10 a.m. on an analyst an...",
"url": "https://www.gurufocus.com/news/2806621/beam-to-discuss-advances-in-aatd-therapy-at-upcoming-conference-call-beam-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BPMU.png?20",
"language": "en",
"published_at": "2025-04-26T20:30:10.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BEAM",
"name": "Beam Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.205482,
"sentiment_score": 0.1361,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+299 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+255 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+68 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "39aaea2f-ece6-4e82-b3de-cf9e5fbeb07a",
"title": "Tesla rises prices in Canada, pushes pre-tariff inventory: report",
"description": "Discover Tesla's pre-tariff priced inventory in Canada before tariffs impact prices.",
"keywords": "",
"snippet": "Tesla (NASDAQ:TSLA) is raising prices in Canada and encouraging buyers in the country to purchase cars imported before Ottawa’s reciprocal tariffs on US-made ...",
"url": "https://seekingalpha.com/news/4436058-tesla-rises-prices-in-canada-pushes-pre-tariff-inventory-report",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2199484412/image_2199484412.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2025-04-26T20:18:49.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 36.420586,
"sentiment_score": 0.23835,
"highlights": [
{
"highlight": "<em>Tesla</em> (<em>NASDAQ:TSLA</em>) is[+266 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tesla</em> rises prices in Canada, pushes pre-tariff inventory: report",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Example response
marketaux is Incredibly Powerful and Easy-to-Use
Get the latest financial and stock market news from top news sources. Use our API to access clean and relevant financial news and analysis.
Over 200,000 entities tracked every minute
We track over 80 global markets with news from more than 5,000 quality sources in 30+ languages.
Concise analysis of only relevant text allows us to generate superior analytics for stocks and other entities.
VIEW SUPPORTED ENTITIESAdvanced language processing technology
Our NLP technology allows us to identify critical details within news articles.
Our tracked entities include stocks, indices, ETFs, commodities, mutual funds, futures, currencies and crypto, complete with relevant analysis.
GET FREE API KEY
Frequent Asked Questions
Our service is 100% free to use on our free plan - no payment details are required.
Each time the API is used to access financial news or analysis data, 1 API request is added to your daily usage. The number of requests allowed for your account depends on which subscription plan you are on.
Yes, paying annually will provide you 2 months free per year (20% discount). To register for a yearly plan, simply go to our pricing page while logged in and select a plan and you will be prompted to pay monthly or annually.